Foresite Capital Management Closes $100 Million Growth Capital Fund to Finance Late-Stage Healthcare Companies

Foresite Capital Management Closes $100 Million Growth Capital Fund to Finance 
Late-Stage Healthcare Companies 
SAN FRANCISCO, CA -- (Marketwire) -- 01/31/13 --  Foresite Capital
Management, LLC, a growth equity firm founded by Jim Tananbaum to
finance late-stage healthcare companies, today announced the close of
its $100 million fund, Foresite Capital Fund I. The firm draws on
Tananbaum and his partners' deep experience and expertise in building
leading healthcare companies, as well as their broad private and
public investment experience.  
"We are marrying the best practices of growth investing with
healthcare specialization," said Jim Tananbaum, founder and managing
director of Foresite Capital Management. "We are proud of our capital
base, extremely excited about the prospects for healthcare growth,
and believe on a risk-adjusted basis there has never been a better
time to have this focus." 
Foresite Capital invests in companies with disruptive, late-stage
products and services in a broad range of healthcare from
biotechnology, genomics and diagnostics to healthcare services and
medical devices. Current portfolio companies include AcelRx
Pharmaceuticals (NASDAQ: ACRX), Intarcia Therapeutics, Keryx
Biopharmaceuticals (NASDAQ: KERX), Puma Biotechnology (NYSE: PBYI),
Solta Medical (NASDAQ: SLTM), and Tarsa Therapeutics.  
About Foresite Capital Management 
Foresite Capital Management was founded in 2011 by veteran healthcare
investor Jim Tananbaum based on his vision to build a firm focused on
providing growth capital to healthcare companies with disruptive
late-stage products or services. Foresite Capital consists of five
partners based in San Francisco and New York. The team has a diverse
set of healthcare expertise, deep experience in private and public
healthcare investing, and a strong track record of building companies
and delivering investor returns. During the last two decades Foresite
Capital's partners have led financings that produced five
multi-billion dollar outcomes. The team's experience also includes
leadership positions in operations, clinical, marketing, business
development, communications, and finance. Foresite Capital is based
in San Francisco, California with an office in Manhattan, New York. 
Contact:
Brewlife (On behalf of Foresite Capital Management)
http://www.brewlife.com
Julie Normart 
415-946-1087 
jnormart@w20group.com 
 
 
Press spacebar to pause and continue. Press esc to stop.